You are here

ArsenalBio

ArsenalBio lands $70M cash deal with cancer giant Genentech to develop cell therapy

Endpoints

Tue, 09/27/22 - 10:30 am

BMS Kicks Off 2021 with $70 Million Collab for Next-Gen T Cell Cancer Therapies

BioSpace

Thu, 01/7/21 - 12:35 pm

Bristol-Myers Squibb

t-cell therapies

Sean Parker-Backed ArsenalBio Wants To Create Better Weapons Against Cancer

Forbes

Fri, 10/18/19 - 09:41 am

precision medicine

ArsenalBio Launches With $85M for “Programmable” T Cell Therapies

Xconomy

Thu, 10/17/19 - 10:26 am